Cooperative behavior of fluoroquinolone combinations against Escherichia coli and Staphylococcus aureus

4Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

The effects of different combinations of ciprofloxacin (CIP) and norfloxacin (NOR) against Escherichia coli and Staphylococcus aureus were studied using checkerboard, fractional inhibitory concentration (FIC) and time-kill analysis methods. Results obtained by the checkerboard method showed that the more effectives combinations against Escherichia coli were 0.0009 μg/mL CIP0.0312 μg/mL NOR and 0.0037 μg/mL CIP0.0075 μg/mL NOR with a FIC index of 0.62. For Staphylococcus aureus, the combination of 0.0625 μg/mL CIP0.2500 μg/mL NOR showed a synergistic effect, with a FIC index of 0.50. The results of the time-kill method demonstrated either indifference or additivity of the combinations 0.0009 μg/mL CIP+0.0312 μg/mL NOR, 0.0018 μg/mL CIP+0.0312 μg/mL NOR, 0.0037 μg/mL CIP+0.0075 μg/mL NOR and 0.0037 μg/mL CIP+0.0156 μg/mL NOR at 24 h against E. coli. The combination 0.0037 μg/mL CIP+0.0312 μg/mL NOR showed synergistic activity. All the analyzed combinations evidenced bactericidal effects at 4 h. The combinations 0.0625 μg/mL CIP+0.2500 μg/mL NOR and 0.0625 μg/mL CIP+0.0625 μg/mL NOR showed indifference or additivity against S. aureus. None of them generated bactericidal effect at 4 h. Moreover, this last equimolecular combination (equivalent to 1/4 minimum inhibitory concentration (MIC) CIP+1/16 MIC NOR) generated higher reduction of nitro blue tetrazolium than drugs alone. By another way, combinations not equimolecular of CIP and NOR assayed, generated less levels of reactive oxygen species (ROS) than the components alone.

References Powered by Scopus

DNA topoisomerases and their poisoning by anticancer and antibacterial drugs

1541Citations
N/AReaders
Get full text

Mechanism of quinolone action and resistance

946Citations
N/AReaders
Get full text

Fluoroquinolone resistance: Mechanisms, impact on bacteria, and role in evolutionary success

741Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Recent updates of fluoroquinolones as antibacterial agents

144Citations
N/AReaders
Get full text

Preliminary investigation of the antibacterial activity of antitumor drug 3-amino-1,2,4-benzotriazine-1,4-dioxide (Tirapazamine) and its derivatives

4Citations
N/AReaders
Get full text

Reduction of Electron-Rich Nitro Heteroarenes; A Comprehensive Review

3Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Vitorino, G. P., Becerra, M. C., Barrera, G. D., Caira, M. R., & Mazzieri, M. R. (2017). Cooperative behavior of fluoroquinolone combinations against Escherichia coli and Staphylococcus aureus. Biological and Pharmaceutical Bulletin, 40(6), 758–764. https://doi.org/10.1248/bpb.b16-00616

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 5

63%

Researcher 2

25%

Professor / Associate Prof. 1

13%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 5

45%

Chemistry 3

27%

Immunology and Microbiology 2

18%

Pharmacology, Toxicology and Pharmaceut... 1

9%

Save time finding and organizing research with Mendeley

Sign up for free